1. An Initiative to Decrease Laboratory Testing in a NICU
- Author
-
Renee Brockett, Caitlin Thursland, Richard Pando, Christopher J. Klunk, Renee E. Barrett, Matthew J. Bizzarro, Eleanor Blythe, Amber M Natusch, Steven M. Peterec, Patrick G. Gallagher, and Marta Kenney
- Subjects
Blood Glucose ,medicine.medical_specialty ,Quality management ,Point-of-care testing ,Psychological intervention ,Pain ,Blood volume ,Hemorrhage ,Unnecessary Procedures ,Laboratory testing ,03 medical and health sciences ,0302 clinical medicine ,Blood loss ,030225 pediatrics ,Intensive Care Units, Neonatal ,Medicine ,Humans ,Guideline development ,Adverse effect ,Monitoring, Physiologic ,Blood Volume ,business.industry ,Infant, Newborn ,Bilirubin ,Carbon Dioxide ,Hospitals, Pediatric ,Laboratories, Hospital ,Quality Improvement ,Connecticut ,Point-of-Care Testing ,Pediatrics, Perinatology and Child Health ,Emergency medicine ,business ,Procedures and Techniques Utilization - Abstract
BACKGROUND AND OBJECTIVES Laboratory testing is performed frequently in the NICU. Unnecessary tests can result in increased costs, blood loss, and pain, which can increase the risk of long-term growth and neurodevelopmental impairment. Our aim was to decrease routine screening laboratory testing in all infants admitted to our NICU by 20% over a 24-month period. METHODS We designed and implemented a multifaceted quality improvement project using the Institute for Healthcare Improvement’s Model for Improvement. Baseline data were reviewed and analyzed to prioritize order of interventions. The primary outcome measure was number of laboratory tests performed per 1000 patient days. Secondary outcome measures included number of blood glucose and serum bilirubin tests per 1000 patient days, blood volume removed per 1000 patient days, and cost. Extreme laboratory values were tracked and reviewed as balancing measures. Statistical process control charts were used to track measures over time. RESULTS Over a 24-month period, we achieved a 26.8% decrease in laboratory tests performed per 1000 patient days (∽51 000 fewer tests). We observed significant decreases in all secondary measures, including a decrease of almost 8 L of blood drawn and a savings of $258 000. No extreme laboratory values were deemed attributable to the interventions. Improvement was sustained for an additional 7 months. CONCLUSIONS Targeted interventions, including guideline development, dashboard creation and distribution, electronic medical record optimization, and expansion of noninvasive and point-of-care testing resulted in a significant and sustained reduction in laboratory testing without notable adverse effects.
- Published
- 2020